HALOZYME THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
HALOZYME THERAPEUTICS, INC. (HALO) reported Basic Shares Outstanding (Weighted Average) of 117.27 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- HALOZYME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 117.27M shares, a 3.35% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 118.14M shares, a 4.12% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 117.65M shares, a 6.92% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 117.22M shares, a 7.59% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 119.84M shares, a 5.51% decline from fiscal 2024.
- HALOZYME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 126.83M shares, a 3.87% decline from fiscal 2023.
- HALOZYME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 131.93M shares, a 3.59% decline from fiscal 2022.
- HALOZYME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 136.84M shares, a 2.70% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 117.27M shares 10-Q · filed 2026-08-06 | 117.71M shares 10-Q · filed 2026-08-06 | 117.69M shares derived: average of 3 quarters · filed 2026-08-06 | 117.57M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 118.14M shares 10-Q · filed 2026-05-11 | 117.90M shares derived: average of 2 quarters · filed 2026-05-11 | 117.67M shares derived: average of 3 quarters · filed 2026-05-11 | 118.59M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 117.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 117.43M shares derived: average of 2 quarters · filed 2026-02-17 | 118.74M shares derived: average of 3 quarters · filed 2026-08-06 | 119.84M shares 10-K · filed 2026-02-17 |
| 2025-09-30 | 117.22M shares 10-Q · filed 2025-11-03 | 119.28M shares derived: average of 2 quarters · filed 2026-08-06 | 120.57M shares 10-Q · filed 2025-11-03 | 122.04M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 121.34M shares 10-Q · filed 2026-08-06 | 122.27M shares 10-Q · filed 2026-08-06 | 123.65M shares derived: average of 3 quarters · filed 2026-08-06 | 124.45M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 123.22M shares 10-Q · filed 2026-05-11 | 124.81M shares derived: average of 2 quarters · filed 2026-05-11 | 125.49M shares derived: average of 3 quarters · filed 2026-05-11 | 125.90M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 126.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 126.63M shares derived: average of 2 quarters · filed 2026-02-17 | 126.79M shares derived: average of 3 quarters · filed 2026-02-17 | 126.83M shares 10-K · filed 2026-02-17 |
| 2024-09-30 | 126.85M shares 10-Q · filed 2025-11-03 | 126.98M shares derived: average of 2 quarters · filed 2025-11-03 | 126.97M shares 10-Q · filed 2025-11-03 | 127.48M shares derived: average of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | 127.12M shares 10-Q · filed 2025-08-05 | 127.03M shares 10-Q · filed 2025-08-05 | 127.69M shares derived: average of 3 quarters · filed 2026-02-17 | 128.76M shares derived: average of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | 126.94M shares 10-Q · filed 2025-05-06 | 127.98M shares derived: average of 2 quarters · filed 2026-02-17 | 129.31M shares derived: average of 3 quarters · filed 2026-02-17 | 129.91M shares derived: average of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | 129.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 130.49M shares derived: average of 2 quarters · filed 2026-02-17 | 130.91M shares derived: average of 3 quarters · filed 2026-02-17 | 131.93M shares 10-K · filed 2026-02-17 |
| 2023-09-30 | 131.97M shares 10-Q · filed 2024-10-31 | 131.85M shares derived: average of 2 quarters · filed 2024-10-31 | 132.90M shares 10-Q · filed 2024-10-31 | 133.50M shares derived: average of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | 131.73M shares 10-Q · filed 2024-08-06 | 133.37M shares 10-Q · filed 2024-08-06 | 134.01M shares derived: average of 3 quarters · filed 2025-02-18 | 134.64M shares derived: average of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | 135.03M shares 10-Q · filed 2024-05-07 | 135.15M shares derived: average of 2 quarters · filed 2025-02-18 | 135.61M shares derived: average of 3 quarters · filed 2025-02-18 | 136.19M shares derived: average of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | 135.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 135.90M shares derived: average of 2 quarters · filed 2025-02-18 | 136.58M shares derived: average of 3 quarters · filed 2025-02-18 | 136.84M shares 10-K · filed 2025-02-18 |
| 2022-09-30 | 136.53M shares 10-Q · filed 2023-11-06 | 137.23M shares derived: average of 2 quarters · filed 2023-11-06 | 137.37M shares 10-Q · filed 2023-11-06 | 138.07M shares derived: average of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | 137.94M shares 10-Q · filed 2023-08-08 | 137.80M shares 10-Q · filed 2023-08-08 | 138.58M shares derived: average of 3 quarters · filed 2024-02-20 | 139.44M shares derived: average of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | 137.66M shares 10-Q · filed 2023-05-09 | 138.90M shares derived: average of 2 quarters · filed 2024-02-20 | 139.94M shares derived: average of 3 quarters · filed 2024-02-20 | 140.58M shares derived: average of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | 140.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | 141.08M shares derived: average of 2 quarters · filed 2024-02-20 | 141.55M shares derived: average of 3 quarters · filed 2024-02-20 | 140.65M shares 10-K · filed 2024-02-20 |
| 2021-09-30 | 142.02M shares 10-Q · filed 2022-11-08 | 142.25M shares derived: average of 2 quarters · filed 2022-11-08 | 140.81M shares 10-Q · filed 2022-11-08 | 139.39M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 142.49M shares 10-Q · filed 2022-08-09 | 140.20M shares 10-Q · filed 2022-08-09 | 138.52M shares derived: average of 3 quarters · filed 2022-08-09 | 138.03M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 137.95M shares 10-Q · filed 2022-05-10 | 136.53M shares derived: average of 2 quarters · filed 2022-05-10 | 136.55M shares derived: average of 3 quarters · filed 2022-05-10 | 136.39M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 135.11M shares 10-K · filed 2021-02-23 | 135.84M shares derived: average of 2 quarters · filed 2021-11-02 | 135.87M shares derived: average of 3 quarters · filed 2021-11-02 | 136.21M shares 10-K · filed 2023-02-21 |
| 2020-09-30 | 136.58M shares 10-Q · filed 2021-11-02 | 136.26M shares derived: average of 2 quarters · filed 2021-11-02 | 136.57M shares 10-Q · filed 2021-11-02 | 137.69M shares derived: average of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | 135.94M shares 10-Q · filed 2021-08-09 | 136.57M shares 10-Q · filed 2021-08-09 | 138.06M shares derived: average of 3 quarters · filed 2021-08-09 | 140.08M shares derived: average of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | 137.19M shares 10-Q · filed 2021-05-10 | 139.12M shares derived: average of 2 quarters · filed 2021-05-10 | 141.46M shares derived: average of 3 quarters · filed 2021-05-10 | 142.44M shares derived: average of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | 141.05M shares 10-K · filed 2021-02-23 | 143.59M shares derived: average of 2 quarters · filed 2021-02-23 | 144.20M shares derived: average of 3 quarters · filed 2021-02-23 | 144.33M shares 10-K · filed 2022-02-22 |
| 2019-09-30 | 146.14M shares 10-K · filed 2021-02-23 | 145.77M shares derived: average of 2 quarters · filed 2021-02-23 | 145.44M shares 10-Q · filed 2020-11-02 | 145.12M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | 145.41M shares 10-K · filed 2021-02-23 | 145.05M shares 10-Q · filed 2020-08-10 | 144.79M shares derived: average of 3 quarters · filed 2021-02-23 | 144.58M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | 144.74M shares 10-K · filed 2021-02-23 | 144.47M shares derived: average of 2 quarters · filed 2021-02-23 | 144.30M shares derived: average of 3 quarters · filed 2021-02-23 | 144.12M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | 144.20M shares 10-K · filed 2020-02-24 | 144.08M shares derived: average of 2 quarters · filed 2020-02-24 | 143.91M shares derived: average of 3 quarters · filed 2020-02-24 | 143.60M shares 10-K · filed 2021-02-23 |
| 2018-09-30 | 143.95M shares 10-K · filed 2020-02-24 | 143.76M shares derived: average of 2 quarters · filed 2020-02-24 | 143.40M shares 10-Q · filed 2018-11-06 | 142.97M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | 143.57M shares 10-K · filed 2020-02-24 | 143.11M shares 10-Q · filed 2018-08-07 | 142.65M shares derived: average of 3 quarters · filed 2020-02-24 | 142.28M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | 142.66M shares 10-K · filed 2020-02-24 | 142.19M shares derived: average of 2 quarters · filed 2020-02-24 | 141.85M shares derived: average of 3 quarters · filed 2020-02-24 | 139.89M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | 141.72M shares 10-K · filed 2019-02-21 | 141.45M shares derived: average of 2 quarters · filed 2019-02-21 | 138.97M shares derived: average of 3 quarters · filed 2019-02-21 | 136.42M shares 10-K · filed 2020-02-24 |
| 2017-09-30 | 141.19M shares 10-K · filed 2019-02-21 | 137.60M shares derived: average of 2 quarters · filed 2019-02-21 | 134.63M shares 10-Q · filed 2018-11-06 | 132.75M shares derived: average of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | 134.01M shares 10-K · filed 2019-02-21 | 131.30M shares 10-Q · filed 2018-08-07 | 129.94M shares derived: average of 3 quarters · filed 2019-02-21 | 129.49M shares derived: average of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | 128.62M shares 10-K · filed 2019-02-21 | 127.91M shares derived: average of 2 quarters · filed 2019-02-21 | 127.99M shares derived: average of 3 quarters · filed 2019-02-21 | 127.98M shares derived: average of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | 127.20M shares 10-K · filed 2017-02-28 | 127.68M shares derived: average of 2 quarters · filed 2017-11-07 | 127.77M shares derived: average of 3 quarters · filed 2017-11-07 | 127.96M shares 10-K · filed 2019-02-21 |
| 2016-09-30 | 128.15M shares 10-Q · filed 2017-11-07 | 128.06M shares derived: average of 2 quarters · filed 2017-11-07 | 127.89M shares 10-Q · filed 2017-11-07 | 127.73M shares derived: average of 4 quarters · filed 2017-11-07 |
| 2016-06-30 | 127.96M shares 10-Q · filed 2017-08-08 | 127.79M shares 10-Q · filed 2017-08-08 | 127.59M shares derived: average of 3 quarters · filed 2017-08-08 | 127.42M shares derived: average of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | 127.61M shares 10-Q · filed 2017-05-09 | 127.41M shares derived: average of 2 quarters · filed 2017-05-09 | 127.24M shares derived: average of 3 quarters · filed 2017-05-09 | 126.97M shares derived: average of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | 127.20M shares 10-K · filed 2016-02-29 | 127.06M shares derived: average of 2 quarters · filed 2016-11-07 | 126.75M shares derived: average of 3 quarters · filed 2016-11-07 | 126.70M shares 10-K · filed 2018-02-20 |
| 2015-09-30 | 126.92M shares 10-Q · filed 2016-11-07 | 126.53M shares derived: average of 2 quarters · filed 2016-11-07 | 126.13M shares 10-Q · filed 2016-11-07 | |
| 2015-06-30 | 126.14M shares 10-Q · filed 2016-08-09 | 125.72M shares 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | 125.30M shares 10-Q · filed 2016-05-09 | |||
| 2014-09-30 | 124.04M shares 10-Q · filed 2015-11-09 | 123.88M shares derived: average of 2 quarters · filed 2015-11-09 | 122.16M shares 10-Q · filed 2015-11-09 | |
| 2014-06-30 | 123.71M shares 10-Q · filed 2015-08-10 | 121.20M shares 10-Q · filed 2015-08-10 | ||
| 2012-09-30 | 112.31M shares 10-Q · filed 2012-11-08 | 112.18M shares derived: average of 2 quarters · filed 2012-11-08 | 110.66M shares 10-Q · filed 2012-11-08 | |
| 2012-06-30 | 112.06M shares 10-Q · filed 2012-08-09 | 109.83M shares 10-Q · filed 2012-08-09 | ||
| 2011-12-31 | 103.41M shares 10-K · filed 2013-03-01 | 103.31M shares derived: average of 2 quarters · filed 2013-03-01 | 103.10M shares derived: average of 3 quarters · filed 2013-03-01 | 102.56M shares derived: average of 4 quarters · filed 2013-03-01 |
| 2011-09-30 | 103.22M shares 10-K · filed 2013-03-01 | 102.95M shares derived: average of 2 quarters · filed 2013-03-01 | 102.28M shares 10-Q · filed 2012-11-08 | |
| 2011-06-30 | 102.67M shares 10-K · filed 2013-03-01 | 101.80M shares 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | 100.93M shares 10-K · filed 2013-03-01 | |||
| 2010-09-30 | 93.63M shares 10-Q · filed 2011-11-08 | 92.70M shares derived: average of 2 quarters · filed 2011-11-08 | 92.34M shares 10-Q · filed 2011-11-08 | |
| 2010-06-30 | 91.77M shares 10-Q · filed 2011-08-05 | 91.69M shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |